PATENT CLAIM ANALYSIS

Application Number: 15764283
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "532000"]

Abstract:
The present invention relates to novel macrocyclic sulfondiimine compounds of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

Claim (Index 8):
The compound of formula (I) according to  claim 1 , wherein\n L represents a \u2014CH 2 CH 2 CH 2 \u2014 or a \u2014CH 2 CH 2 CH 2 CH 2 \u2014 group; X, Y represent CH or N with the proviso that one of X and Y represents CH and one of X and Y represents N; R 1  represents a methyl-group; R 2  represents a hydrogen atom or a cyano group; R 3  represents a fluorine atom; R 4  represents a hydrogen atom or a fluorine atom; R 5  represents a group selected from a hydrogen atom, cyano, methyl-, 3-hydroxypropyl- and cyclopropyl-; or an enantiomer, diastereomer, salt, solvate or salt of solvate thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.65909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15303212', '15764289', '14345353', '14443368', '14443180']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8287560273616049
- 35 USC 102 Novelty (BERT): 0.6000915535766954
- Combined Prediction Score: 0.8058895799831141
- Mean Citation Score: 421.604676
- Max Citation Score: 531.68835
- Similarity Product: 472.4501505289257

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test